Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Heparin Induced Thrombocytopenia”

50 trials

Showing 20 of 50 results

Post-approval studies (Phase 4)Ended earlyNCT00798525
What this trial is testing

Argatroban Versus Lepirudin in Critically Ill Patients

Who this might be right for
Heparin Induced Thrombocytopenia (HIT)
Heinrich-Heine University, Duesseldorf 70
Testing effectiveness (Phase 2)Ended earlyNCT03594045
What this trial is testing

Efficacy and Safety of Apixaban in the Treatment of Heparin Induced Thrombocytopenia (HIT)

Who this might be right for
Heparin-induced ThrombocytopeniaHeparin-induced Thrombocytopenia and Thrombosis
Massachusetts General Hospital 5
Not applicableStudy completedNCT00748839
What this trial is testing

Heparin-Induced Thrombocytopenia: Development and Validation of a Predictive Clinical

Who this might be right for
Heparin-induced Thrombocytopenia
Centre Hospitalier Universitaire de Saint Etienne 2,700
Not applicableLooking for participantsNCT02717039
What this trial is testing

Pharmacogenomics of Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
University of Arizona 125
Not applicableUnknownNCT06180785
What this trial is testing

Performance Evaluation of the Biological Diagnosis of HIT

Who this might be right for
Heparin-induced Thrombocytopenia (HIT)
University Hospital, Strasbourg, France 894
Not applicableStudy completedNCT01654848
What this trial is testing

Heparin-induced Thrombocytopenia (HIT II) in Liver Transplant Recipients

Who this might be right for
Heparin-induced ThrombocytopeniaLiver Transplantation
CHIR-Net 39
Large-scale testing (Phase 3)Study completedNCT00329433
What this trial is testing

Study Comparing Desirudin With Heparin to Prevent Vein Clots After Heart and Lung Surgery

Who this might be right for
Deep Venous Thrombosis
Washington University School of Medicine 120
Large-scale testing (Phase 3)Study completedNCT00043940
What this trial is testing

Anticoagulant Therapy With Bivalirudin in the Performance of Percutaneous Coronary Intervention in Patients With Heparin-Induced Thrombocytopenia (AT BAT, First Inning)

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosis
The Medicines Company 50
Not applicableUnknownNCT04782843
What this trial is testing

Evaluation of the Intra-observer Agreement of the HEP Score in Surgical Intensive Care.

Who this might be right for
Heparin-induced Thrombocytopenia
Centre Hospitalier Universitaire de Besancon 124
Not applicableStudy completedNCT00283322
What this trial is testing

Heparin Antibodies in Intensive Care Unit Patients (HAICU)

Who this might be right for
Heparin-Induced Thrombocytopenia
The University of Texas Health Science Center, Houston 185
Not applicableUnknownNCT01102790
What this trial is testing

Generation of Heparin-induced Thrombocytopenia (HIT)-Antibodies Without Prior Heparin Exposure

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosis
Johann Wolfgang Goethe University Hospital 160
Post-approval studies (Phase 4)Ended earlyNCT00787332
What this trial is testing

A Comparative Sudy Comparing Argatroban® IV vs Desirudin SC for Suspected HIT With or Without Thrombosis Syndrome

Who this might be right for
Suspected Heparin-Induced Thrombocytopenia
Canyon Pharmaceuticals, Inc. 16
Not applicableUnknownNCT05783895
What this trial is testing

Comparison of Pre-test Probability Model for Heparin-induced Thrombocytopenia in Post-operative Cardiac Surgery

Who this might be right for
Heparin-induced Thrombocytopenia
Central Hospital, Nancy, France 200
Early research (Phase 1)Study completedNCT00489437
What this trial is testing

Heparin-Induced Thrombocytopenia Score Card Study

Who this might be right for
Heparin-Induced Thrombocytopenia
McMaster University 536
Large-scale testing (Phase 3)Ended earlyNCT01598168
What this trial is testing

Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia

Who this might be right for
Heparin-induced Thrombocytopenia
McMaster University 22
Post-approval studies (Phase 4)Study completedNCT00039858
What this trial is testing

Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin

Who this might be right for
ThrombocytopeniaThrombosis
Encysive Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT00861692
What this trial is testing

Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

Who this might be right for
Heparin-induced Thrombocytopenia Type II
Tanabe Pharma Corporation 20
Post-approval studies (Phase 4)UnknownNCT00196417
What this trial is testing

The HIT-TRAP Trial

Who this might be right for
Heparin-Induced Thrombocytopenia
University Medicine Greifswald 600
Not applicableUnknownNCT03269019
What this trial is testing

Thrombotic Biomarkers to Predict Thrombosis in Heparin-induced Thrombocytopenia

Who this might be right for
Heparin-Induced ThrombocytopeniaThrombosisBiomarkers
Wuhan Asia Heart Hospital 200
Not applicableUnknownNCT06066762
What this trial is testing

Argatroban Monitoring in Acute Suspected Heparin-induced Thrombocytopenia.

Who this might be right for
Heparin-induced Thrombocytopenia
Assistance Publique - Hôpitaux de Paris 200
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation